Table 1.
Patient Characteristics.
| Age, year | 48.6±18.0 | |
| Sex | Male 13 / Female 28 | |
| Height (cm) | 161.5±9.5 | |
| Body weight (kg) | 54.9±10.0 | |
| Body mass index (kg/m2) | 21.0±2.9 | |
| Systolic BP (mmHg) | 117.2±15.5 | |
| Diastolic BP (mmHg) | 72.1±10.3 | |
| Heart rate (/min) | 66.2±7.3 | |
| sCr (mg/dL) | 0.99±0.42 | |
| eGFR (mL/min/1.73m2) | 62.3±23.0 | |
| CKD stage | Stage 1: 5/Stage 2: 17/Stage 3: 14/Stage 4: 5/Stage 5: 0 | |
| Plasma Ang II (pg/mL) | 11.7±5.8 | |
| Urinary Alb/day (mg/day) | 268.7 [110.5-848.8] | |
| Log u-Alb/day (mg/day) | 2.48±0.60 | |
| Log u-Alb/Cr (μg/mg) | 2.47±0.64 | |
| Urinary AGT/day (ng/day) | 59,279.3 [30,700.2-192,933.6] | |
| Log u-AGT/day (ng/day) | 4.96±0.76 | |
| Log u-AGT/Cr (ng/mg) | 1.96±0.82 | |
| Log u-AGT/Alb (ng/mg) | 2.49±0.79 | |
| Urinary α1MG (mg/L) | 7.60 [3.03-17.03] | |
| Log u-α1MG (mg/L) | 0.93±0.53 | |
| Interstitial fibrosis (%) | 25.7±20.9 |
BP: blood pressure, sCr: serum creatinine, eGFR: estimated glomerular filtration rate, CKD: chronic kidney disease, Ang II: angiotensin II, u-Alb/day: urinary albumin/day, u-Alb/Cr: urinary albumin to creatinine ratio, u-AGT/day: urinary angiotensinogen/day, u-AGT/Cr: urinary angiotensinogen to creatinine ratio, u-AGT/Alb: urinary angiotensinogen to albumin ratio, u-α1MG: urinary alpha 1 microglobulin